These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 6687837)

  • 21. [Combination chemotherapy of advanced gastric cancer with adriamycin, mitomycin C, and ftorafur].
    Miyamoto H; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Ikeda K; Usui N; Nakada H; Okada Y
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1160-4. PubMed ID: 6408998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Undifferentiated leukemia following treatment of gastric cancer with 5 fluorouracil, doxorubicin, mitomycin C chemotherapy.
    Gupta S; Raina V; Jain P; Gujral S; Kumar R
    J Assoc Physicians India; 2000 Jun; 48(6):639-40. PubMed ID: 11273547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
    Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
    Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of metastatic pancreatic and gastric adenocarcinomas with 5-fluorouracil, adriamycin, and mitomycin C (FAM).
    Bitran JD; Desser RK; Kozloff MF; Billings AA; Shapiro CM
    Cancer Treat Rep; 1979; 63(11-12):2049-51. PubMed ID: 393388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL; Gutiérrez LE
    Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
    [No Abstract]   [Full Text] [Related]  

  • 26. Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
    Logothetis CJ; von Eschenbach AC; Samuels ML; Trindade A; Johnson DE
    Cancer Treat Rep; 1982 Jan; 66(1):57-63. PubMed ID: 7053267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adjuvant chemotherapy in advanced stomach cancer].
    Zehner J; Weber L; Fischer M; Gfirtner H; Breit A
    Med Klin (Munich); 1986 Jun; 81(13):445-8. PubMed ID: 3785030
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chemotherapy of gastrointestinal cancer in elderly patients--evaluation of combination therapy with mitomycin C and 5-fluorouracil].
    Fujii M; Murakami N; Matsuka Y; Ejiri T; Asano K
    Gan No Rinsho; 1983 Feb; 29(2):A-8, 129-32. PubMed ID: 6308301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma. Fluorouracil vs fluorouracil and doxorubicin vs fluorouracil, doxorubicin, and mitomycin.
    Cullinan SA; Moertel CG; Fleming TR; Rubin JR; Krook JE; Everson LK; Windschitl HE; Twito DI; Marschke RF; Foley JF
    JAMA; 1985 Apr; 253(14):2061-7. PubMed ID: 2579257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase II study of 5-fluorouracil, doxorubicin, and mitomycin C for metastatic small bowel adenocarcinoma.
    Gibson MK; Holcroft CA; Kvols LK; Haller D
    Oncologist; 2005 Feb; 10(2):132-7. PubMed ID: 15709215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Medical decision in clinical oncology: the example of drug therapy of gastric cancer in the advanced stage during the last decade].
    Kenis Y
    Bull Cancer; 1987; 74(2):191-5. PubMed ID: 3607302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of patients with metastatic adenocarcinoma of unknown origin: a Southwest Oncology Group study.
    Shildt RA; Kennedy PS; Chen TT; Athens JW; O'Bryan RM; Balcerzak SP
    Cancer Treat Rep; 1983 Jan; 67(1):77-9. PubMed ID: 6616495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A gastric cancer patient who underwent curative resection by angiotension-induced hypertension cancer chemotherapy].
    Hakuta Y; Kimura T; Ashizawa I; Sato S; Hara T; Nakazima K
    Gan No Rinsho; 1984 Jan; 30(1):66-9. PubMed ID: 6422102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin].
    Repetto L; Campora E; Nobile MT; Rosso R
    G Ital Chemioter; 1985; 32(1):57-8. PubMed ID: 3841661
    [No Abstract]   [Full Text] [Related]  

  • 36. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
    Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of intrahepatic bile duct cancer responding to 5-fluorouracil, adriamycin and mitomycin C chemotherapy].
    Uchiyama K; Takada T; Yasuda H; Hasegawa H; Tsuchiya S; Misu Y; Saitoh Y; Shikata J; Kozakai M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1987-90. PubMed ID: 3132897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy].
    Hara K; Yokoyama T; Furuta K; Shinoda M; Yajima K; Yasuda S; Nakazaki S; Kiyomitsu Y; Watanabe K
    Gan No Rinsho; 1984 Apr; 30(4):399-402. PubMed ID: 6727041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Eastern Cooperative Oncology Group evaluation of combinations of methyl-CCNU, mitomycin C, Adriamycin, and 5-fluorouracil in advanced measurable gastric cancer (EST 2277).
    Douglass HO; Lavin PT; Goudsmit A; Klaassen DJ; Paul AR
    J Clin Oncol; 1984 Dec; 2(12):1372-81. PubMed ID: 6439836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experience of a combination chemotherapy consisting of 5-FU, MMC, and FT-207--side effects against kidney].
    Yamada F; Kagami H; Fukutome A; Mastumine T; Miura T
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2049-54. PubMed ID: 6412636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.